(R)-(-)-Dapoxetine

GA01151

Dapoxetine is the first compound developed specially for the treatment of premature ejaculation in men 18 to 64 years old. Dapoxetine works by inhibiting the serotonin transporter, increasing serotonin’s action at the post synaptic cleft, and as a consequence promoting ejaculatory delay.

We have successfully synthesized standards of the Dapoxetine. This will be of interest to pharmaceutical companies and analytical labs.